Cargando…
Does neurofibromatosis 1 status impact outcomes for pediatric/young adults undergoing spinal fusion?
BACKGROUND: Although spinal deformities are common in patients with neurofibromatosis type 1 (NF1), there is a paucity of data as to how this impacts outcomes of spinal fusion surgery in pediatric/young adult patients. METHODS: Using the Nationwide Inpatient Sample (2005–2014) for all patients under...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific Scholar
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193189/ https://www.ncbi.nlm.nih.gov/pubmed/32363055 http://dx.doi.org/10.25259/SNI_39_2020 |
_version_ | 1783528146024267776 |
---|---|
author | Freedman, Isaac Koo, Andrew Yeagle, Erin Diluna, Michael Kolb, Luis Yeung, Jacky |
author_facet | Freedman, Isaac Koo, Andrew Yeagle, Erin Diluna, Michael Kolb, Luis Yeung, Jacky |
author_sort | Freedman, Isaac |
collection | PubMed |
description | BACKGROUND: Although spinal deformities are common in patients with neurofibromatosis type 1 (NF1), there is a paucity of data as to how this impacts outcomes of spinal fusion surgery in pediatric/young adult patients. METHODS: Using the Nationwide Inpatient Sample (2005–2014) for all patients undergoing spinal fusion ≤26 years of age, we compared the following factors: demographics, comorbidities, and perioperative variables (e.g., between NF1 vs. non-NF1, and between NF1 and propensity score (PS)-matched non- NF1 spinal fusion patients) using univariate hypothesis tests and multivariate regression analyses. Our main interest focused on length of stay, complication rates, adverse postoperative events, and incidence of nonroutine discharges. RESULTS: In this study, 238 (0.92%) NF1 spine patients were compared to 25,558 (99.08%) non-NF1 spine patients. NF1 fusion patients were younger, included fewer females, and were more likely to be on Medicaid. Perioperatively, NF1 patients underwent more anterior approaches, had more vertebrae fused, required more transfusions, had a longer length of stay (LOS), and were less likely to be discharged home. However, after PS- matching, all differences between NF1 and non-NF1 groups disappeared were similar (P > 0.05). In PS-matched multivariate analyses, NF1-status was not a significant independent predictor of length of stay or nonroutine discharge disposition. CONCLUSION: NF1-status was, therefore, not an independent predictor of complications, adverse postoperative events, longer LOS, or nonroutine hospital discharge in this cohort analysis. Further prospective studies are necessary to understand how outcomes in patients with NF1 compare to non-NF1 pediatric and young adult patients. |
format | Online Article Text |
id | pubmed-7193189 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Scientific Scholar |
record_format | MEDLINE/PubMed |
spelling | pubmed-71931892020-05-01 Does neurofibromatosis 1 status impact outcomes for pediatric/young adults undergoing spinal fusion? Freedman, Isaac Koo, Andrew Yeagle, Erin Diluna, Michael Kolb, Luis Yeung, Jacky Surg Neurol Int Original Article BACKGROUND: Although spinal deformities are common in patients with neurofibromatosis type 1 (NF1), there is a paucity of data as to how this impacts outcomes of spinal fusion surgery in pediatric/young adult patients. METHODS: Using the Nationwide Inpatient Sample (2005–2014) for all patients undergoing spinal fusion ≤26 years of age, we compared the following factors: demographics, comorbidities, and perioperative variables (e.g., between NF1 vs. non-NF1, and between NF1 and propensity score (PS)-matched non- NF1 spinal fusion patients) using univariate hypothesis tests and multivariate regression analyses. Our main interest focused on length of stay, complication rates, adverse postoperative events, and incidence of nonroutine discharges. RESULTS: In this study, 238 (0.92%) NF1 spine patients were compared to 25,558 (99.08%) non-NF1 spine patients. NF1 fusion patients were younger, included fewer females, and were more likely to be on Medicaid. Perioperatively, NF1 patients underwent more anterior approaches, had more vertebrae fused, required more transfusions, had a longer length of stay (LOS), and were less likely to be discharged home. However, after PS- matching, all differences between NF1 and non-NF1 groups disappeared were similar (P > 0.05). In PS-matched multivariate analyses, NF1-status was not a significant independent predictor of length of stay or nonroutine discharge disposition. CONCLUSION: NF1-status was, therefore, not an independent predictor of complications, adverse postoperative events, longer LOS, or nonroutine hospital discharge in this cohort analysis. Further prospective studies are necessary to understand how outcomes in patients with NF1 compare to non-NF1 pediatric and young adult patients. Scientific Scholar 2020-04-04 /pmc/articles/PMC7193189/ /pubmed/32363055 http://dx.doi.org/10.25259/SNI_39_2020 Text en Copyright: © 2020 Surgical Neurology International http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Freedman, Isaac Koo, Andrew Yeagle, Erin Diluna, Michael Kolb, Luis Yeung, Jacky Does neurofibromatosis 1 status impact outcomes for pediatric/young adults undergoing spinal fusion? |
title | Does neurofibromatosis 1 status impact outcomes for pediatric/young adults undergoing spinal fusion? |
title_full | Does neurofibromatosis 1 status impact outcomes for pediatric/young adults undergoing spinal fusion? |
title_fullStr | Does neurofibromatosis 1 status impact outcomes for pediatric/young adults undergoing spinal fusion? |
title_full_unstemmed | Does neurofibromatosis 1 status impact outcomes for pediatric/young adults undergoing spinal fusion? |
title_short | Does neurofibromatosis 1 status impact outcomes for pediatric/young adults undergoing spinal fusion? |
title_sort | does neurofibromatosis 1 status impact outcomes for pediatric/young adults undergoing spinal fusion? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193189/ https://www.ncbi.nlm.nih.gov/pubmed/32363055 http://dx.doi.org/10.25259/SNI_39_2020 |
work_keys_str_mv | AT freedmanisaac doesneurofibromatosis1statusimpactoutcomesforpediatricyoungadultsundergoingspinalfusion AT kooandrew doesneurofibromatosis1statusimpactoutcomesforpediatricyoungadultsundergoingspinalfusion AT yeagleerin doesneurofibromatosis1statusimpactoutcomesforpediatricyoungadultsundergoingspinalfusion AT dilunamichael doesneurofibromatosis1statusimpactoutcomesforpediatricyoungadultsundergoingspinalfusion AT kolbluis doesneurofibromatosis1statusimpactoutcomesforpediatricyoungadultsundergoingspinalfusion AT yeungjacky doesneurofibromatosis1statusimpactoutcomesforpediatricyoungadultsundergoingspinalfusion |